Cannabix Technologies AI Stock Analysis
Want to see TSE:BLO full AI Analyst Report?
Cannabix Technologies (BLO) AI Stock Analysis
Cannabix Technologies
(CNQX:BLO)
The overall score is severely constrained by the company's dire financial position, which is the most significant factor. Cannabix has no revenue, widening losses, and a rapidly shrinking asset base, indicating a critical need for external financing. While short-term technicals show some positive momentum, this is a secondary factor that does not offset the fundamental risk. The negative P/E ratio confirms the lack of earnings, making the stock a highly speculative investment.
Cannabix Technologies (BLO) vs. iShares MSCI Canada ETF (EWC)
- Market Cap
- CAD 32.59M
- Dividend Yield
- ―
- Average Volume (3M)
- 32.34K
- Price to Earnings (P/E)
- -11.8
- Beta (1Y)
- -0.14
- Revenue Growth
- ―
- EPS Growth
- -84.43%
- Country
- Canada
- Employees
- 0
- Sector
- Healthcare
- Sector Strength
- 51
- Industry
- Other Precious Metals
Cannabix Technologies Business Overview & Revenue Model
Company Description
Cannabix Technologies Inc., a technology company, develops marijuana and alcohol breathalyzer technologies for employers, law enforcement, workplaces, and laboratories in the United States. It offers Cannabix Marijuana Breath Test (MBT) for Tetrahydr...
Cannabix Technologies Financial Statement Overview
Summary
Cannabix Technologies is a pre-revenue company with no sales and escalating net losses, reaching -$5.8M annually. The balance sheet shows rapidly eroding equity and assets, while cash flow is entirely negative with a short cash runway. Overall financial health is extremely poor, posing an existential risk without new funding.
Income Statement
1Very NegativeBalance Sheet
25NegativeCash Flow
10Very Negative| Breakdown | TTM | Jul 2026 | Jul 2025 | Jul 2024 | Jul 2023 | Jul 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | -1 | 0 | 0 | 0 | 0 | 0 |
| Gross Profit | -261.54K | -172.97K | -168.52K | -153.24K | -126.29K | -29.22K |
| EBITDA | -5.73M | -5.83M | -4.42M | -2.96M | -2.01M | -3.11M |
| Net Income | -5.76M | -5.76M | -4.69M | -3.13M | -2.14M | -3.37M |
Balance Sheet | ||||||
| Total Assets | 2.21M | 2.21M | 3.00M | 4.70M | 6.95M | 8.76M |
| Cash, Cash Equivalents and Short-Term Investments | 1.59M | 1.59M | 2.35M | 4.26M | 6.52M | 8.45M |
| Total Debt | 160.06K | 160.06K | 158.65K | 154.58K | 132.54K | 0 |
| Total Liabilities | 431.71K | 431.71K | 447.71K | 248.02K | 237.17K | 120.84K |
| Stockholders Equity | 1.78M | 1.78M | 2.55M | 4.45M | 6.71M | 8.64M |
Cash Flow | ||||||
| Free Cash Flow | -1.74M | -1.74M | -1.86M | -2.11M | -2.00M | -2.13M |
| Operating Cash Flow | -1.74M | -1.74M | -1.84M | -2.08M | -1.97M | -2.13M |
| Investing Cash Flow | 0 | 0 | -17.54K | -30.96K | -28.65K | -4,592 |
| Financing Cash Flow | 968.26K | 968.26K | -58.47K | -143.53K | 10.88K | 492.50K |
Cannabix Technologies Technical Analysis
Price Trends
Market Momentum
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For TSE:BLO, the sentiment is Negative. The current price of 0.37 is below the 20-day moving average (MA) of 0.42, below the 50-day MA of 0.39, and below the 200-day MA of 0.56, indicating a bearish trend. The MACD of -0.01 indicates Positive momentum. The RSI at 46.01 is Neutral, neither overbought nor oversold. The STOCH value of 33.33 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for TSE:BLO.
Cannabix Technologies Peers Comparison
Overall Rating
TSE:BLO46Neutral
TSE:PINK44Neutral
TSE:VPT39Underperform
Financial Indicators
| Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
| Sector * | 51Neutral | $7.86B | -0.30 | -43.30% | 2.27% | 22.53% | -2.21% |
| 46Neutral | CAD 45.58M | -11.79 | -232.36% | ― | ― | -84.43% | |
| 44Neutral | CAD 20.71M | -1.03 | -303.05% | ― | 35.27% | 58.34% | |
| 39Underperform | CAD 13.50M | -5.36 | 56.40% | ― | 89.06% | 37.62% |
* Healthcare Sector Average
Performance Comparison
| Show on chart | Ticker | Company Name | Price | Change | % Change |
|---|---|---|---|---|---|
| TSE:BLO | Cannabix | 0.37 | -0.18 | -32.73% | |
| TSE:PINK | Perimeter Medical Imaging Ai Inc | 0.14 | -0.04 | -25.00% | |
| TSE:VPT | VentriPoint Diagnostics | 0.07 | -0.02 | -22.22% |
Cannabix Technologies Corporate Events
Cannabix Reports Fentanyl Detection in Human Breath
PositiveCannabix Technologies reported detecting fentanyl in human breath samples collected with its Breath Collection Unit and disposable Breath Cartridges, then confirmed by Omega Laboratories using liquid chromatography-mass spectrometry. Because fentanyl...
Cannabix launches DOT-like breath-based multi-drug test panel for recent-use detection
PositiveCannabix Technologies Inc., a Vancouver-based developer of breath-based marijuana and alcohol testing solutions, focuses on non-invasive tools that enhance public and workplace safety by identifying recent impairment rather than historical drug use....
Cannabix Files Patent for Rapid Point-of-Care Marijuana Breath Test
PositiveCannabix Technologies has filed a U.S. provisional patent application for a rapid, point-of-care marijuana breath test that combines its proprietary Breath Collection Unit and Breath Cartridge with lateral flow assay platforms. The proposed system is...
Cannabix’s BreathLogix Enters U.S. Manufacturing Market with Alabama Deployment
PositiveCannabix Technologies has deployed its BreathLogix alcohol screening solution at a manufacturing facility in Alabama, marking the product’s first delivery to a U.S.-based manufacturing company. The system, distributed through reseller AlcoPro, will s...
Cannabix Expands BreathLogix Alcohol Monitoring Deployment in Montana
PositiveCannabix Technologies has deployed its BreathLogix alcohol screening system at the Big Horn County Misdemeanor Probation and Pre-trial Services department in Montana, expanding its footprint under the state’s 24/7 Sobriety Program. The device, instal...
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.
Date of analysis: Oct 22, 2026
